{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "24345752"
      ],
      "tumorType":{
        "children":{},
        "code":"AITL",
        "color":"LimeGreen",
        "id":264,
        "level":5,
        "mainType":{
          "id":null,
          "name":"Mature T and NK Neoplasms",
          "tumorForm":"LIQUID"
        },
        "name":"Angioimmunoblastic T-Cell Lymphoma",
        "parent":"MTNN",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx3",
      "pmids":[
        "22237106"
      ],
      "tumorType":{
        "children":{},
        "code":"ETPLL",
        "color":"LimeGreen",
        "id":857,
        "level":4,
        "mainType":{
          "id":null,
          "name":"T-Lymphoblastic Leukemia/Lymphoma",
          "tumorForm":"LIQUID"
        },
        "name":"Early T-Cell Precursor Lymphoblastic Leukemia",
        "parent":"TLL",
        "tissue":"Lymphoid",
        "tumorForm":"LIQUID"
      }
    },
    {
      "abstracts":[],
      "alterations":[
        "Oncogenic Mutations"
      ],
      "description":"",
      "levelOfEvidence":"LEVEL_Dx2",
      "pmids":[
        "21415852"
      ],
      "tumorType":{
        "children":{},
        "code":"MDS",
        "color":"LightSalmon",
        "id":355,
        "level":3,
        "mainType":{
          "id":null,
          "name":"Myelodysplastic Syndromes",
          "tumorForm":"LIQUID"
        },
        "name":"Myelodysplastic Syndromes",
        "parent":"MNM",
        "tissue":"Myeloid",
        "tumorForm":"LIQUID"
      }
    }
  ],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"DNMT3A, a tumor suppressor and DNA methyltransferase, is recurrently mutated in acute myeloid leukemia and other hematologic malignancies.",
  "highestDiagnosticImplicationLevel":"LEVEL_Dx2",
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"10/04/2018",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "24614070",
        "21067377",
        "25964253"
      ]
    },
    "description":"Truncating mutations in DNMT3A have been detected in patients with acute myeloid leukemia (AML) and developmental overgrowth disorders (PMID: 25964253, 24614070). These alterations are predicted to cause nonsense-mediated decay and haploinsufficiency, and are associated with a better survival and lower relapse risk in AML (PMID: 25964253). Give the role of DNMT3A in DNA methylation, loss results in disturbed methylation patterns and global hypomethylation, which is required for transcription of lineage-specific programs in myeloid development (PMID: 21067377).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"G543Afs*108",
    "alterationType":null,
    "consequence":"frameshift_variant",
    "entrezGeneId":1788,
    "hgvs":null,
    "hugoSymbol":"DNMT3A",
    "id":null,
    "proteinEnd":543,
    "proteinStart":543,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The DNMT3A G543Afs*108 mutation is likely oncogenic.",
  "vus":false
}